Article
Early Use of Low Dose Rituximab in Anti Acetylcholine Receptor Generalised Myasthenia Gravis in South Wales – a Retrospective Study
2026-06-08
Abstract excerpt
<title>Abstract</title> <p>Background Early B-cell depletion with rituximab may improve outcomes in acetylcholine receptor (AChR)–positive generalized myasthenia gravis (MG), but data on early low-dose use are limited. Objective To assess the effectiveness, steroid-sparing effect, and safety of early low-dose rituximab in non-thymomatous, immunosuppression-naïve generalized AChR-positive MG. Methods Retrospect...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c3ed46f3-0e8c-581d-a784-67ae366f8d89
- DOI
- 10.21203/rs.3.rs-9552683/v1
